Retraction
Upregulated Expression Levels of ADAM10 and EGFR and Downregulated Expression Levels of E-cadherin in Hepatocellular Carcinomas
Paper Information
Record ID:
4827
Author(s):
Journal:
Publication Date:
October 10, 2013
Retraction Date:
June 03, 2014
(11.5 years years ago)
Subjects:
Institutions:
- Department of Pharmacy, First Affiliated Hospital of Medical College of Xi’an Jiaotong University, Xi’an, Shaanxi 710061, P.R. China
- The Hospital of Luonan, Luonan, Shaanxi 726100, P.R. China
- Department of Hepatobiliary Surgery, First Affiliated Hospital of Medical College of Xi’an Jiaotong University, Xi’an, Shaanxi 710061, P.R. China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Spandidos
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (4)
4
Total Citations4
Post-Retraction(100.0%)
0
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
2
After 2+ years
3834
Days since retraction (latest)
Paper citing Upregulated Expression Levels of ADAM10 and EGFR a...
Unknown Authors
Unknown Journal
Published: Dec 2024
3834 days after retraction
Paper citing Upregulated Expression Levels of ADAM10 and EGFR a...
Unknown Authors
Unknown Journal
Published: Feb 2017
980 days after retraction
Paper citing Upregulated Expression Levels of ADAM10 and EGFR a...
Unknown Authors
Unknown Journal
Published: Sep 2014
114 days after retraction
Paper citing Upregulated Expression Levels of ADAM10 and EGFR a...
Unknown Authors
Unknown Journal
Published: Jul 2014
43 days after retraction
Quick Stats
Total Citations:
4
Years Since Retraction:
11.5 years
Open Access:
Yes
Last Checked:
Never